The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
Clinical trials sponsored by The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School, explained in plain language.
-
When to start Weight-Loss drug after surgery? new study investigates
Disease control CompletedThis study involved 100 adults who were still obese 6 months after weight-loss surgery. Researchers compared starting the drug liraglutide early versus later to see which timing leads to greater weight loss and health improvements. The goal is to find the best way to help patient…
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 17, 2026 03:25 UTC
-
New pill shows promise for Hard-to-Treat high blood pressure
Disease control CompletedThis study tested a new drug called finerenone in 55 adults with primary aldosteronism, a condition where the body makes too much of a hormone that raises blood pressure. The goal was to see if finerenone can safely lower blood pressure over 12 weeks. Researchers measured how muc…
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Massive study reveals hidden liver dangers in seniors
Knowledge-focused CompletedThis study looked at 10,000 elderly patients (age 60+) with fatty liver disease to find out what increases their risk for serious liver problems like scarring, cirrhosis, and liver cancer. Researchers collected health data over time and used computer models to predict who might d…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated May 17, 2026 03:30 UTC